Sex hormones limit cancer immunotherapy success

Scientists have discovered how the sex hormone androgen, most commonly testosterone in men, can limit the body’s response to cancer immunotherapy, a finding that may help make those therapies more...

New clues to what turns prostate cancers deadly

Only a fraction of prostate cancers become life threatening, but it’s impossible to predict which ones. In a surprising new study, researchers found that two signaling proteins used by nerve cells...

For veterans with prostate cancer, a new center of excellence in Oregon

VA Portland Health Care System and OHSU are launching a precision oncology center of excellence supported by the Prostate Cancer Foundation. On Veteran's Day, the foundation announced $5 million in...

Interrogating cancer, one cell at a time: Q&A with Hisham Mohammed

Hisham Mohammed, Ph.D., helped create a way to peer into individual cells and take multiple measures of gene activity and gene regulation at the same time. He’s leading the first research to apply...

Advancing immunotherapy for life-threatening prostate cancer

Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...

Top papers in prostate cancer co-authored by OHSU faculty

Physician-scientists with the OHSU Knight Cancer Institute co-authored three of the 25 most important prostate cancer studies published this year, and one runner up, as judged by the Prostate Cancer...